https://www.indianpharmapost.com/wockhardt-reports-q1-fy26-loss-at-rs-108-cr-175702025-08-10T00:00:00+05:30always0.9https://www.indianpharmapost.com/gandhar-oil-refinery-india-reports-q1-fy26-consolidated-pat-lower-at-rs-261-cr-yoy-175712025-08-10T00:00:00+05:30always0.9https://www.indianpharmapost.com/divis-laboratories-posts-consolidated-q1-fy26-pat-of-rs-545-cr-175722025-08-10T00:00:00+05:30always0.9https://www.indianpharmapost.com/morepen-laboratories-consolidated-q1-fy26-pat-lower-at-rs-1140-cr-175732025-08-10T00:00:00+05:30always0.9https://www.indianpharmapost.com/kims-q1-fy26-consolidated-profit-slips-to-rs-786-cr-175742025-08-10T00:00:00+05:30always0.9https://www.indianpharmapost.com/aurobindo-pharma-q1-fy26-pat-slips-10-yoy-to-rs-824-cr-175752025-08-10T00:00:00+05:30always0.9